Ventrus Biosciences (VTUS) Files 949K Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts VTUS Hot Sheet
Join SI Premium – FREE
Ventrus Biosciences (Nasdaq: VTUS) filed a registration with the U.S. Securities and Exchange commission to sell, from time to time, up to 948,378 shares of Common Stock on behalf of Selling Shareholders.
Ventrus will not receive proceeds from the secondary offering.
Ventrus will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rainier Acquisition prices $75M IPO on Nasdaq
- Change Agents announces 1-for-20 reverse stock split on Nasdaq
- SEC drops all claims against Live Ventures in case dating to 2017
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
